首页> 美国卫生研究院文献>BMC Cancer >Active DNA end processing in micronuclei of ovarian cancer cells
【2h】

Active DNA end processing in micronuclei of ovarian cancer cells

机译:卵巢癌细胞微核中的活性DNA末端加工

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundOvarian cancer is one of the most deadly gynecological malignancies and inclined to recurrence and drug resistance. Previous studies showed that the tumorigenesis of ovarian cancers and their major histotypes are associated with genomic instability caused by defined sets of pathogenic mutations. In contrast, the mechanism that influences the development of drug resistance and disease recurrence is not well elucidated. Solid tumors are prone to chromosomal instability (CIN) and micronuclei formation (MN). Although MN is traditionally regarded as the outcome of genomic instability, recent investigation on its origin and final consequences reveal that the abnormal DNA metabolism in MN is a driver force for some types of catastrophic genomic rearrangements, accelerating dramatic genetic variation of cancer cells.
机译:背景卵巢癌是最致命的妇科恶性肿瘤之一,倾向于复发和耐药。先前的研究表明,卵巢癌的肿瘤发生及其主要组织类型与特定的致病突变集引起的基因组不稳定有关。相反,尚未充分阐明影响耐药性和疾病复发的机制。实体瘤易于发生染色体不稳定(CIN)和微核形成(MN)。尽管传统上将MN视为基因组不稳定的结果,但最近对其起源和最终结果的研究表明,MN中异常的DNA代谢是某些类型的灾难性基因组重排的驱动力,加速了癌细胞的显着遗传变异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号